Juul Labs Agrees to Pay $438.5 Million Settlement

Sep.07.2022
Juul Labs Agrees to Pay $438.5 Million Settlement
Juul Labs to pay $438.5 million in a two-year settlement over marketing and sales practices that targeted youth.

On Tuesday, Juul Labs agreed to a $438.5 million settlement across multiple states, concluding a two-year bipartisan investigation into the e-cigarette manufacturer's marketing and sales practices that targeted youth.


In a statement, Juul stated that the settlement agreement is "an important component of our ongoing commitment to addressing past issues. Recently, we provided scientific and evidentiary proof to the US Food and Drug Administration that its marketing denial order (MDO) regarding our products was flawed both substantively and procedurally, and should be revoked.


According to the office of the Texas Attorney General, the agreement also includes marketing restrictions for individuals under the age of 35, limitations on in-store and online displays and sales, as well as age verification requirements for all sales.


Texas Attorney General Ken Paxton stated, "My commitment to protecting consumers from deceptive business practices is unwavering, and any company that misleads Texans, especially our young people, will be held accountable for their actions.


The state of Texas will receive $42.8 million from a settlement. The Attorney General's office stated that the $438.5 million settlement will be paid out over a period of 5 to 10 years, but if Juul chooses to extend the payment schedule to the maximum timeframe, the settlement amount could reach $476.6 million.


In late 2018, cigarette manufacturer Altria, maker of Marlboro, acquired a 35% stake in Juul for approximately $13 billion. As of July of this year, these shares were estimated to be valued at $4.5 billion.


This article contains excerpts or reprints sourced from third-party information, whose copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual that needs to reprint must contact the author and should not directly reprint the content.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s federal prosecutors sue for strict e-cigarette rules, urging regulation over a “paper ban”
Brazil’s Federal Public Prosecutor’s Office (MPF) has filed a public civil action seeking to compel the federal government and Anvisa to establish a strict, enforceable regulatory framework for electronic smoking devices, replacing the current blanket ban. The lawsuit calls for mandatory product registration, nicotine caps, bans on youth-targeted advertising, and clear health warnings on packaging, and demands a national consumption report and an implementation timetable within 90 days.
Jan.30 by 2FIRSTS.ai
Cambodia: Phnom Penh authorities seize 2,000+ vape devices and arrest two alleged distributors
Cambodia: Phnom Penh authorities seize 2,000+ vape devices and arrest two alleged distributors
Kiripost reports that authorities seized more than 2,000 electronic smoking devices and arrested two alleged distributors in Phnom Penh’s Toul Kork district, prompting health advocates to warn that inconsistent enforcement is undermining Cambodia’s crackdown on illegal e-cigarettes and shisha.
Jan.13 by 2FIRSTS.ai
Thai police arrest 23-year-old woman linked to major vape-smuggling network in the South
Thai police arrest 23-year-old woman linked to major vape-smuggling network in the South
Thai police said officers expanded an investigation into a major e-cigarette smuggling network in the South and arrested a 23-year-old woman at Hat Yai Junction railway station on Jan. 6, 2026.
Jan.08 by 2FIRSTS.ai